Cargando…
Regulation of Prepro-NeuropeptideW/B and Its Receptor in the Heart of ZDF Rats: An Animal Model of Type II DM
Neuropeptide B (NPB) and neuropeptide W (NPW) are neuropeptides, which constitute NPB/W signaling systems together with G-protein coupled receptors NPBWR1. The location and function of NPB/W signaling systems have been predominantly detected and mapped within the CNS, including their role in the mod...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739957/ https://www.ncbi.nlm.nih.gov/pubmed/36499546 http://dx.doi.org/10.3390/ijms232315219 |
_version_ | 1784847938349957120 |
---|---|
author | Pandey, Shashank Jarkovska, Dagmar Tuma, Zdenek Smrhova, Tereza Chottova Dvorakova, Magdalena |
author_facet | Pandey, Shashank Jarkovska, Dagmar Tuma, Zdenek Smrhova, Tereza Chottova Dvorakova, Magdalena |
author_sort | Pandey, Shashank |
collection | PubMed |
description | Neuropeptide B (NPB) and neuropeptide W (NPW) are neuropeptides, which constitute NPB/W signaling systems together with G-protein coupled receptors NPBWR1. The location and function of NPB/W signaling systems have been predominantly detected and mapped within the CNS, including their role in the modulation of inflammatory pain, neuroendocrine functions, and autonomic nervous systems. The aim of the study is to investigate the impact of diabetes on the neuropeptide B/W signaling system in different heart compartments and neurons which innervates it. In the RT-qPCR analysis, we observed the upregulation of mRNA for preproNPB in RV, for preproNPW in LA, and for NPBWR1 in DRG in diabetic rats. On the contrary, the expression of mRNA for NPBWR1 was downregulated in LV in diabetic rats. In the WB analysis, significant downregulation of NPBWR1 in LV (0.54-fold, p = 0.046) in diabetic rats was observed at the proteomic level. The presence of NPBWR1 was also confirmed in a dissected LCM section of cardiomyocytes and coronary arteries. The positive inotropic effect of NPW described on the diabetic cardiomyocytes in vitro could point to a possible therapeutic target for compensation of the contractile dysfunction in the diabetic heart. In conclusion, the NPB/W signaling system is involved in the regulation of heart functions and long-term diabetes leads to changes in the expression of individual members of this signaling system differently in each cardiac compartment, which is related to the different morphology and function of these cardiac chambers. |
format | Online Article Text |
id | pubmed-9739957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97399572022-12-11 Regulation of Prepro-NeuropeptideW/B and Its Receptor in the Heart of ZDF Rats: An Animal Model of Type II DM Pandey, Shashank Jarkovska, Dagmar Tuma, Zdenek Smrhova, Tereza Chottova Dvorakova, Magdalena Int J Mol Sci Article Neuropeptide B (NPB) and neuropeptide W (NPW) are neuropeptides, which constitute NPB/W signaling systems together with G-protein coupled receptors NPBWR1. The location and function of NPB/W signaling systems have been predominantly detected and mapped within the CNS, including their role in the modulation of inflammatory pain, neuroendocrine functions, and autonomic nervous systems. The aim of the study is to investigate the impact of diabetes on the neuropeptide B/W signaling system in different heart compartments and neurons which innervates it. In the RT-qPCR analysis, we observed the upregulation of mRNA for preproNPB in RV, for preproNPW in LA, and for NPBWR1 in DRG in diabetic rats. On the contrary, the expression of mRNA for NPBWR1 was downregulated in LV in diabetic rats. In the WB analysis, significant downregulation of NPBWR1 in LV (0.54-fold, p = 0.046) in diabetic rats was observed at the proteomic level. The presence of NPBWR1 was also confirmed in a dissected LCM section of cardiomyocytes and coronary arteries. The positive inotropic effect of NPW described on the diabetic cardiomyocytes in vitro could point to a possible therapeutic target for compensation of the contractile dysfunction in the diabetic heart. In conclusion, the NPB/W signaling system is involved in the regulation of heart functions and long-term diabetes leads to changes in the expression of individual members of this signaling system differently in each cardiac compartment, which is related to the different morphology and function of these cardiac chambers. MDPI 2022-12-02 /pmc/articles/PMC9739957/ /pubmed/36499546 http://dx.doi.org/10.3390/ijms232315219 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pandey, Shashank Jarkovska, Dagmar Tuma, Zdenek Smrhova, Tereza Chottova Dvorakova, Magdalena Regulation of Prepro-NeuropeptideW/B and Its Receptor in the Heart of ZDF Rats: An Animal Model of Type II DM |
title | Regulation of Prepro-NeuropeptideW/B and Its Receptor in the Heart of ZDF Rats: An Animal Model of Type II DM |
title_full | Regulation of Prepro-NeuropeptideW/B and Its Receptor in the Heart of ZDF Rats: An Animal Model of Type II DM |
title_fullStr | Regulation of Prepro-NeuropeptideW/B and Its Receptor in the Heart of ZDF Rats: An Animal Model of Type II DM |
title_full_unstemmed | Regulation of Prepro-NeuropeptideW/B and Its Receptor in the Heart of ZDF Rats: An Animal Model of Type II DM |
title_short | Regulation of Prepro-NeuropeptideW/B and Its Receptor in the Heart of ZDF Rats: An Animal Model of Type II DM |
title_sort | regulation of prepro-neuropeptidew/b and its receptor in the heart of zdf rats: an animal model of type ii dm |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739957/ https://www.ncbi.nlm.nih.gov/pubmed/36499546 http://dx.doi.org/10.3390/ijms232315219 |
work_keys_str_mv | AT pandeyshashank regulationofpreproneuropeptidewbanditsreceptorintheheartofzdfratsananimalmodeloftypeiidm AT jarkovskadagmar regulationofpreproneuropeptidewbanditsreceptorintheheartofzdfratsananimalmodeloftypeiidm AT tumazdenek regulationofpreproneuropeptidewbanditsreceptorintheheartofzdfratsananimalmodeloftypeiidm AT smrhovatereza regulationofpreproneuropeptidewbanditsreceptorintheheartofzdfratsananimalmodeloftypeiidm AT chottovadvorakovamagdalena regulationofpreproneuropeptidewbanditsreceptorintheheartofzdfratsananimalmodeloftypeiidm |